Aspiriant Holdings S3’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$3.27M Buy
88,908
+11,518
+15% +$432K 1.4% 28
2015
Q3
$2.76M Sell
77,390
-55,740
-42% -$2.14M 1.27% 35
2015
Q2
$5.28M Buy
133,130
+107,340
+416% +$4.44M 2.11% 11
2015
Q1
$1.03M Sell
25,790
-13,825
-35% -$542K 0.41% 67
2014
Q4
$1.5M Buy
39,615
+1,980
+5% +$76.7K 0.62% 56
2014
Q3
$1.5M Buy
37,635
+1,375
+4% +$57.2K 0.6% 52
2014
Q2
$1.54M Buy
36,260
+4,130
+13% +$174K 0.61% 51
2014
Q1
$1.33M Buy
32,130
+27,035
+531% +$1.11M 0.56% 53
2013
Q4
$212K Buy
+5,095
New +$207K 0.08% 103

Other funds holding VEA

Aspiriant Holdings S3's VEA Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 15% in Q4 2015, buying an estimated $432K and bringing the position to 88,908 shares worth $3.27M. The position accounts for 1.4% of the portfolio, ranked #28.

Aspiriant Holdings S3 first reported a position in VEA in Q4 2013 and has held it in 9 quarters since. The position peaked at $5.28M in Q2 2015. 631 funds tracked by Wall St. Rank hold VEA as of Q4 2015.

  • Aspiriant Holdings S3 held 88,908 shares of Vanguard FTSE Developed Markets ETF worth $3.27M as of Q4 2015.
  • Aspiriant Holdings S3 bought 11,518 Vanguard FTSE Developed Markets ETF shares in Q4 2015, an estimated $432K.
  • Vanguard FTSE Developed Markets ETF made up 1.4% of Aspiriant Holdings S3's portfolio in Q4 2015, its #28 holding.
  • Aspiriant Holdings S3 first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2013 and has held it in 9 quarters since.
  • Aspiriant Holdings S3's Vanguard FTSE Developed Markets ETF position peaked at $5.28M in Q2 2015.
  • 631 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.